Trophoblasts, collected from the mother during a blood draw, can determine fetal genetic abnormalities currently diagnosed through amniocentesis or chorionic villi sampling.
The latest restrictions require scientists to submit more comprehensive grant applications, and those applications will go through more stringent ethics reviews.